G. Fernández-Pajarín , M. Blanco-Ulla , E. Arán , B. Ares , P. Román-Pena , A. Jesús Mosqueira , I. Jiménez-Martín , M. Gelabert-González , J.M. Prieto-González , Á. Sesar
{"title":"Talamotomía unilateral con ultrasonidos focales de alta intensidad en el temblor refractario. Primeros resultados de un hospital público en España","authors":"G. Fernández-Pajarín , M. Blanco-Ulla , E. Arán , B. Ares , P. Román-Pena , A. Jesús Mosqueira , I. Jiménez-Martín , M. Gelabert-González , J.M. Prieto-González , Á. Sesar","doi":"10.1016/j.nrl.2023.02.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Unilateral high-intensity focused ultrasound (HIFU) thalamotomy is a novel and efficient treatment for refractory tremor. In the most recent studies, the tremor is reduced by at least 70%. The objective of this study is to analyse the results of the first series of cases treated in a public hospital in Spain.</div></div><div><h3>Methods</h3><div>In our centre, from March 2021 to March 2022, 46 patients have undergone a HIFU thalamotomy. The treatment area was predetermined on the inferior surface of the ventral intermediate nucleus of the thalamus using automatic anatomical segmentation on an individual basis. The data of 44 patients 6<!--> <!-->months after the procedure have been analysed.</div></div><div><h3>Results</h3><div>The mean age of the treated patients was 70.5<!--> <!-->±<!--> <!-->14.4 years, and 68% were male. The most common diagnosis was essential tremor (40 cases). Prior to HIFU treatment, the Clinical Rating Scale for Tremor of the treated body side (CRST A<!--> <!-->+<!--> <!-->B) was 22.4<!--> <!-->±<!--> <!-->5.9, and tremor-related disability (CRST C) was 18.3<!--> <!-->±<!--> <!-->4.8. The mean number of sonications was 6.8<!--> <!-->±<!--> <!-->1.7. Six months after treatment, CRST scales were 4.5<!--> <!-->±<!--> <!-->5.6 and 4.2<!--> <!-->±<!--> <!-->5.2, respectively <em>(P</em><.0001). Twenty patients had head tremor. We observed a significant improvement with HIFU (1.9<!--> <!-->±<!--> <!-->0.7 to 0.7<!--> <!-->±<!--> <!-->0.8, <em>P</em><.0001). Only 4<!--> <!-->patients presented adverse effects at 6<!--> <!-->months, all of them mild.</div></div><div><h3>Conclusions</h3><div>The clinical benefit after HIFU thalamotomy reaches an 80% reduction in tremor and has a low rate of adverse effects 6<!--> <!-->months after the procedure. The target localisation method used allowed for fewer sonications.</div></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"40 8","pages":"Pages 739-745"},"PeriodicalIF":3.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213485324001452","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Unilateral high-intensity focused ultrasound (HIFU) thalamotomy is a novel and efficient treatment for refractory tremor. In the most recent studies, the tremor is reduced by at least 70%. The objective of this study is to analyse the results of the first series of cases treated in a public hospital in Spain.
Methods
In our centre, from March 2021 to March 2022, 46 patients have undergone a HIFU thalamotomy. The treatment area was predetermined on the inferior surface of the ventral intermediate nucleus of the thalamus using automatic anatomical segmentation on an individual basis. The data of 44 patients 6 months after the procedure have been analysed.
Results
The mean age of the treated patients was 70.5 ± 14.4 years, and 68% were male. The most common diagnosis was essential tremor (40 cases). Prior to HIFU treatment, the Clinical Rating Scale for Tremor of the treated body side (CRST A + B) was 22.4 ± 5.9, and tremor-related disability (CRST C) was 18.3 ± 4.8. The mean number of sonications was 6.8 ± 1.7. Six months after treatment, CRST scales were 4.5 ± 5.6 and 4.2 ± 5.2, respectively (P<.0001). Twenty patients had head tremor. We observed a significant improvement with HIFU (1.9 ± 0.7 to 0.7 ± 0.8, P<.0001). Only 4 patients presented adverse effects at 6 months, all of them mild.
Conclusions
The clinical benefit after HIFU thalamotomy reaches an 80% reduction in tremor and has a low rate of adverse effects 6 months after the procedure. The target localisation method used allowed for fewer sonications.
期刊介绍:
Neurología es la revista oficial de la Sociedad Española de Neurología y publica, desde 1986 contribuciones científicas en el campo de la neurología clínica y experimental. Los contenidos de Neurología abarcan desde la neuroepidemiología, la clínica neurológica, la gestión y asistencia neurológica y la terapéutica, a la investigación básica en neurociencias aplicada a la neurología. Las áreas temáticas de la revistas incluyen la neurologia infantil, la neuropsicología, la neurorehabilitación y la neurogeriatría. Los artículos publicados en Neurología siguen un proceso de revisión por doble ciego a fin de que los trabajos sean seleccionados atendiendo a su calidad, originalidad e interés y así estén sometidos a un proceso de mejora. El formato de artículos incluye Editoriales, Originales, Revisiones y Cartas al Editor, Neurología es el vehículo de información científica de reconocida calidad en profesionales interesados en la neurología que utilizan el español, como demuestra su inclusión en los más prestigiosos y selectivos índices bibliográficos del mundo.